High-throughput sequencing technologies have changed the way we identify, study and understand the role of rare variation in Mendelian diseases. Sequencing in complex diseases have proven to be more challenging to interpret, but methods and approaches are being developed to aid in our understanding of variation in these diseases.
Identifer | oai:union.ndltd.org:harvard.edu/oai:dash.harvard.edu:1/12274464 |
Date | 04 June 2016 |
Creators | Lim, Teng Ting |
Contributors | Daly, Mark Joseph |
Publisher | Harvard University |
Source Sets | Harvard University |
Language | en_US |
Detected Language | English |
Type | Thesis or Dissertation |
Rights | open |
Page generated in 0.0017 seconds